2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons. (Q39191943)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

María-Paz Viveros

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Alvaro Llorente-Berzal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ana Luisa B Terzian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Vincenzo Micale

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Carsten T Wotjak

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

28 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

2811-2825

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814137%20AND%20SRC:MED&resulttype=core&format=json

Supply and demand for endocannabinoids

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Fear extinction and BDNF: translating animal models of PTSD to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

CB2: a cannabinoid receptor with an identity crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Bimodal control of stimulated food intake by the endocannabinoid system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Targeted mutagenesis tools for modelling psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Towards new approaches to disorders of fear and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

A novel non-CB1/TRPV1 endocannabinoid-mediated mechanism depresses excitatory synapses on hippocampal CA1 interneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Anandamide uptake explained?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Transport of endocannabinoids across the plasma membrane and within the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

A catalytically silent FAAH-1 variant drives anandamide transport in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Evidence against the presence of an anandamide transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Consequences of extinction training on associative and non-associative fear in a mouse model of Posttraumatic Stress Disorder (PTSD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

The study of fear extinction: implications for anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Amygdala FAAH and anandamide: mediating protection and recovery from stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

In vivo knockdown of GAD67 in the amygdala disrupts fear extinction and the anxiolytic-like effect of diazepam in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Individual differences in recovery from traumatic fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Nonassociative learning processes determine expression and extinction of conditioned fear in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Modulation of anxiety through blockade of anandamide hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Early interventions for PTSD: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Bidirectional regulation of novelty-induced behavioral inhibition by the endocannabinoid system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid typ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

The endogenous cannabinoid system controls extinction of aversive memories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Aversive effects of the synthetic cannabinoid CP 55,940 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

The endocannabinoid system and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Bimodal control of fear-coping strategies by CB₁ cannabinoid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Endocannabinoid system and mood disorders: priming a target for new therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

The endocannabinoid system controls key epileptogenic circuits in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Exposure to marijuana smoke impairs memory retrieval in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Fatty-acid amide hydrolase polymorphisms and post-traumatic stress disorder after penetrating brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Implications of memory modulation for post-traumatic stress and fear disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Dissociation of within- and between-session extinction of conditioned fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Cannabinoid activation of recombinant and endogenous vanilloid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

A mouse model of posttraumatic stress disorder that distinguishes between conditioned and sensitised fear.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Differences in extinction of conditioned fear in C57BL/6 substrains are unrelated to expression of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Distribution of diacylglycerol lipase alpha, an endocannabinoid synthesizing enzyme, in the rat forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

The anandamide transport inhibitor AM404 activates vanilloid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3917-Y

Cannabinoids and anxiety.

21 January 2018

1 reference

12 December 2020

Molecular and morphological configuration for 2-arachidonoylglycerol-mediated retrograde signaling at mossy cell-granule cell synapses in the dentate gyrus

1 reference

12 December 2020

Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight

1 reference

12 December 2020

Stress regulates endocannabinoid-CB1 receptor signaling

1 reference

12 December 2020

Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) channels.

1 reference

12 December 2020